Ocugen Inc. Announces Near Completion of Enrollment for OCU400 Phase 3 Clinical Trial, Aiming for BLA Filing by Mid-2026
Ocugen Inc., a biotechnology company specializing in gene therapies for blindness diseases, has announced progress in its clinical trials and upcoming presentations. The company is nearing the completion of enrollment for the OCU400 Phase 3 liMeliGhT clinical trial, with plans to file a Biologics License Application by mid-2026. Additionally, Ocugen will present at the 2025 BIO International Convention, taking place from June 16-19 in Boston. During the convention, Ocugen's leadership will engage with potential partners and discuss its novel gene therapy platform. Dr. Shankar Musunuri, Chairman, CEO, and Co-founder, will present on June 16 and participate in panel discussions on June 17 and 18. Results from the clinical trials have not yet been presented and will be shared in the future.Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for
This guy lives in his own world , prices are very high here of everything
Trump Calls On Fed To Cut Rates, Saying Prices Of "Practically Everything" Are Down
Trump calls on Fed to cut rates, saying prices of 'practically everything' are downMay 13 - U.S. President Donald Trump on Tuesday repeated his call for the Federal Reserve to lower interest rates, saying prices for gas, groceries and "practically everything else" are down."No Inflation, and Prices of Gasoline, Energy, Groceries, and practically everything else, are DOWN!!!THE FED must lower the RATE, like Europe and China have done," Trump said on Truth Social."What is wrong with Too Late Powell?Not fair to America, which is ready to blossom?Just let it all happen, it will be a beautiful thing!," Trump added, repeating criticism of Fed Chairman Jerome Powell.